Factors associated with COVID-19 infection in People Living with HIV. A case-control study nested in a Colombian cohort

被引:0
作者
Alzate-Angel, Juan Carlos [1 ]
Gutierrez-Gomez, Melissa [2 ]
Mueses-Marin, Hector [1 ,3 ]
Valderrama-Beltran, Sandra [1 ,4 ]
Hernandez, Beatriz [1 ,5 ]
Sussmann-Pena, Otto [1 ,5 ]
Martinez-Buitrago, Ernesto [1 ,6 ]
机构
[1] REVIVA Fdn, VIHCOL Grp, Cali, Colombia
[2] Corp Biol Res CIB, Clin Invest Unit, Medellin, Colombia
[3] IDS Fighting Corp, Cali, Colombia
[4] San Ignacio Univ Hosp, Bogota, Colombia
[5] Infectoclinicos, Bogota, Colombia
[6] Valle Univ, Cali, Colombia
关键词
COVID-19; HIV; case and control studies;
D O I
10.22354/24223794.1139
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Objective: People living with HIV (PLWH); can be especially vulnerable to the effects of SARS-Co V-2 and COVID-19. In this study, we evaluate the factors associated with acquiring COVID-19 and the severity of the infection among PLWH. Materials and methods: Through a case-control study nested in a cohort, where cases were PLWH diagnosed with COVID-19; and controls were PLWH without the infection, 476 people were evaluated between May 1, 2020, and February 28, 2021. A univariate analysis was performed with the variables considered candidates. Binary logistic regression models were conducted for the COVID-19 outcome, and among those diagnosed with the infection, regression models for the outcome of hospitalization vs. outpatient treatment. Results: Among 238 PLWH diagnosed with COVID-19, receiving integrase inhibitors p < 0.001 (CI 95% 0.27,0.72) or protease inhibitors p 0.034 (CI 95%0.42,0.97) within their antiretroviral regime, was associated with a lower probability of developing COVID-19. 196 (82,35%) of the 238 cases received outpatient treatment, and 42 (17,64%) required hospitalization. In this case, being older than 50 years p < 0.001 (CI 95% 1.8,9.64) and having obesity as a comorbidity p 0.017 (CI 95% 1.34,17.93) increased the possibility of requiring hospitalization, while receiving antiretroviral treatment or having received vaccination against influenza, decreased the likelihood of this outcome. Conclusions: There are still many questions regarding whether there is a differential risk of acquiring COVID-19 among PLWH. Antiretroviral treatment with integrase or protease inhibitors; was associated with a lower probability of developing the co-infection. Some factors related to comorbidities, such as older age and obesity, draw attention to possible risk factors for hospitalization in this population. Discussing the feasibility of new studies with proposed causal hypotheses that allow directing the research designs toward a more precise answer to these questions is essential.
引用
收藏
页码:150 / 158
页数:9
相关论文
共 12 条
[1]   Potential protease inhibitors and their combinations to block SARS-CoV-2 [J].
Abhinand, Chandran S. ;
Nair, Achuthsankar S. ;
Krishnamurthy, Anand ;
Oommen, Oommen V. ;
Sudhakaran, Perumana R. .
JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS, 2022, 40 (02) :903-917
[2]   HIV and COVID-19: review of clinical course and outcomes [J].
Barbera, Lauren K. ;
Kamis, Kevin F. ;
Rowan, Sarah E. ;
Davis, Amelia J. ;
Shehata, Soraya ;
Carlson, Jesse J. ;
Johnson, Steven C. ;
Erlandson, Kristine M. .
HIV RESEARCH & CLINICAL PRACTICE, 2021, 22 (04) :102-118
[3]   Coronaviruses and Immunosuppressed Patients: The Facts During the Third Epidemic [J].
D'Antiga, Lorenzo .
LIVER TRANSPLANTATION, 2020, 26 (06) :832-834
[4]   Characteristics, Comorbidities, and Outcomes in a Multicenter Registry of Patients With Human Immunodeficiency Virus and Coronavirus Disease 2019 [J].
Dandachi, Dima ;
Geiger, Grant ;
Montgomery, Mary W. ;
Karmen-Tuohy, Savannah ;
Golzy, Mojgan ;
Antar, Annukka A. R. ;
Llibre, Josep M. ;
Camazine, Maraya ;
Diaz-De Santiago, Alberto ;
Carlucci, Philip M. ;
Zacharioudakis, Ioannis M. ;
Rahimian, Joseph ;
Wanjalla, Celestine N. ;
Slim, Jihad ;
Arinze, Folasade ;
Kratz, Ann Marie Porreca ;
Jones, Joyce L. ;
Patel, Shital M. ;
Kitchell, Ellen ;
Francis, Adero ;
Ray, Manoj ;
Koren, David E. ;
Baddley, John W. ;
Hill, Brannon ;
Sax, Paul E. ;
Chow, Jeremy .
CLINICAL INFECTIOUS DISEASES, 2021, 73 (07) :E1964-E1972
[5]   Incidence and Severity of COVID-19 in HIV-Positive Persons Receiving Antiretroviral Therapy A Cohort Study [J].
del Amo, Julia ;
Polo, Rosa ;
Moreno, Santiago ;
Diaz, Asuncion ;
Martinez, Esteban ;
Ramon Arribas, Jose ;
Jarrin, Inma ;
Hernan, Miguel A. .
ANNALS OF INTERNAL MEDICINE, 2020, 173 (07) :536-+
[6]   NESTED CASE-CONTROL STUDIES [J].
ERNSTER, VL .
PREVENTIVE MEDICINE, 1994, 23 (05) :587-590
[7]  
Fondo Colombiano de Enfermedades de Alto Costo, 2020, Situacion del VIH SIDA en Colombia 2019
[8]   Coronavirus disease 2019: What we know? [J].
He, Feng ;
Deng, Yu ;
Li, Weina .
JOURNAL OF MEDICAL VIROLOGY, 2020, 92 (07) :719-725
[9]   Lopinavir-ritonavir in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial [J].
Horby, Peter W. ;
Landray, Martin J. ;
Mafham, Marion ;
Bell, Jennifer L. ;
Linsell, Louise ;
Staplin, Natalie ;
Emberson, Jonathan R. ;
Palfreeman, Adrian ;
Raw, Jason ;
Elmahi, Einas ;
Prudon, Benjamin ;
Green, Christopher ;
Carley, Simon ;
Chadwick, David ;
Davies, Matthew ;
Wise, Matthew P. ;
Baillie, J. Kenneth ;
Chappell, Lucy C. ;
Faust, Saul N. ;
Jaki, Thomas ;
Jeffery, Katie ;
Lim, Wei Shen ;
Montgomery, Alan ;
Rowan, Kathryn ;
Juszczak, Edmund ;
Haynes, Richard .
LANCET, 2020, 396 (10259) :1345-1352
[10]   A simulation study of the number of events per variable in logistic regression analysis [J].
Peduzzi, P ;
Concato, J ;
Kemper, E ;
Holford, TR ;
Feinstein, AR .
JOURNAL OF CLINICAL EPIDEMIOLOGY, 1996, 49 (12) :1373-1379